More than three decades ago, Congress created the 340B program to help safety-net hospitals and clinics expand resources and care for underserved communities. By requiring pharmaceutical companies to ...
The purpose of the U.S. Senate’s 340B Drug Pricing Program bipartisan working group is to advance bipartisan policy solutions to make certain the 340B program can continue to achieve its intended goal ...
A recent proposal from the Trump administration aims to hasten the recovery of $7.8 billion in improper reimbursements for discounted drugs under the 340B program. This initiative, hidden within a ...